SIP
NTUS

Stoneridge Investment Partners’s Natus Medical Inc NTUS Stock Holding History

Stoneridge Investment Partners’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-9,904
Closed -$371K – 277
2017
Q3 		$371K Sell
9,904
-13,139
-57% -$464K 0.06% 156
2017
Q2 		$860K Buy
+23,043
New +$832K 0.13% 120

Other funds holding NTUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Stoneridge Investment Partners's NTUS Position: Q4 2017 in Review

Stoneridge Investment Partners sold out of Natus Medical Inc (NTUS) in Q4 2017, closing a stake of 9,904 shares — an estimated $371K sold.

Stoneridge Investment Partners first reported a position in NTUS in Q2 2017 and held it in 2 quarters. The position peaked at $860K in Q2 2017. 214 funds tracked by Wall St. Rank hold NTUS as of Q4 2017.

  • Stoneridge Investment Partners reported no remaining Natus Medical Inc position as of Q4 2017 after selling out during the quarter.
  • Stoneridge Investment Partners sold 9,904 Natus Medical Inc shares in Q4 2017, an estimated $371K.
  • Stoneridge Investment Partners first reported a position in Natus Medical Inc in Q2 2017 and held it in 2 quarters.
  • Stoneridge Investment Partners's Natus Medical Inc position peaked at $860K in Q2 2017.
  • 214 funds tracked by Wall St. Rank held Natus Medical Inc as of Q4 2017.

Based on Stoneridge Investment Partners's 13F filing for Q4 2017, filed 5 Feb 2018.